SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA's earnings release is the major market focus, with the community anticipating significant movement based on the results and forward guidance. Community members are actively debating whether the stock is priced for perfection, with some expressing concerns about an AI bubble and potential insider selling. Many believe NVIDIA's report will set the tone for the broader tech sector and market recovery, while others foresee a potential sell-off regardless of the outcome.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending amid optimism surrounding deep-sea mining prospects and potential government involvement, with the CEO heading back to Washington. Community members are discussing the possibility of government stakes and key partnerships, especially with rising geopolitical tensions and the need for non-Chinese sourced minerals. Bullish sentiment seems to be fueled by the potential for significant long-term growth in the critical minerals sector.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid the impending release of Epstein files, sparking community debate on potential connections and implications.  Some are pointing fingers at the other side of the political spectrum for alleged association with Epstein. Broader discussions involve market manipulation, stock dilution, and overall performance concerns for the company.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines ($LUNR) is trending as investors await potential LTV and CLPS contract awards, with some anticipating a surprise "golden dome" contract. Community members are closely watching for insider buying and unusual options activity, interpreting them as signals of imminent positive news. Despite recent market downturns and dilution concerns, many maintain a long-term bullish outlook, viewing current prices as a buying opportunity in the space exploration sector.

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Kazia Therapeutics Limited - ADR

Kazia Therapeutics

KZIA is trending due to promising early data from a Phase 1b trial for triple-negative breast cancer, showing a significant reduction in tumor cells. The community is actively discussing the potential for a short squeeze given the low float and high short interest, while also weighing the possibility of a near-term offering. Some investors are optimistic about the drug's potential impact on cancer treatment and are anticipating further data releases.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending due to an increased share repurchase program, signaling confidence in the company's value; the community is actively discussing the potential for a buyout and the impact of the buyback on the stock's float. Despite positive news, concerns about dilution and past stock performance remain talking points, with some investors expressing skepticism towards management.

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Olema Pharmaceuticals is trending due to positive data from a Roche breast cancer trial, which has boosted optimism around Olema's similar treatment and sparked significant volatility. The community is discussing the potential for a short squeeze and a possible offering, with some analysts raising price targets significantly. Some traders express caution due to the lack of direct news from OLMA and the high percentage increase, suggesting a potential pump and dump.

Nutex Health, Inc. engages in the management and operation of healthcare facilities. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The Population Health Division establishes and operates provider networks such as independent physician associations (IPAs). The Real State Division owns land and hospital buildings which are leased to hospital entities. The company was founded in 2011 and is headquartered in Houston, TX.

Nutex Health Inc

Nutex Health is trending due to positive earnings reports and discussions around a potential short squeeze, with retail investors expressing excitement and urging others to hold. Community members are actively debating the impact of a short report from Blue Orca Capital and the company's response, as well as the significance of upcoming earnings and potential Nasdaq compliance. The broader conversation revolves around the company's financials, growth potential, and the possibility of a significant price movement.

The KARRAT protocol is a decentralized gaming infrastructure layer, supported by $KARRAT and empowered by a truly decentralized community with a shared vision embracing gaming, entertainment and AI products catering for the new era.  To accelerate the evolution of gaming, entertainment, and AI-driven experiences with blockchain technology and a truly empowered community.  The KARRAT protocol pioneers a decentralized framework in gaming and entertainment, combining blockchain with community-driven collaboration. $KARRAT can animate ecosystems of games and products and the protocol makes tools available to support these industries and the adoption of KARRAT technology provides a unique, personalized gaming experience.

KARRAT

Karrat is trending amidst community discussions around accumulating the token, particularly after a significant drop from its previous high. Some investors express excitement about the project's potential in the gaming sector and Web 3.0, while others cite concerns about token dilution and overall market conditions. The community is watching for news and potential partnerships that could drive the price upwards, with some also pointing to the upcoming token unlock event.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics is trending as investors anticipate upcoming presentations at the AASLD Liver Meeting and await new biomarker data for Belapectin. The community is buzzing about Belapectin's potential in treating MASH cirrhosis, especially in combination with GLP-1 drugs, and speculating on potential partnerships, buyouts, and a possible short squeeze before year-end.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


vmvm88com

VM88